BioNTech returns to cancer roots with deal for Gilead cell therapy factory

BioNTech returns to cancer roots with deal for Gilead cell therapy factory

Source: 
BioPharma Dive
snippet: 

BioNTech, the German drug developer now best known for the coronavirus vaccine it developed in partnership with Pfizer, will buy a cancer cell therapy factory and related research from Gilead's Kite Pharma unit.